
Alert: Rating Downgrade (2/28/25)-Theravance Biopharma Inc (NASDAQ: TBPH).
Stock Rating Downgrade The Value Trend Rating for Theravance Biopharma Inc (NASDAQ: TBPH) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]